0,864  0,002  5 Hydroxytryptamine release stimulant
0,823  0,003  Alpha 2 adrenoreceptor antagonist
0,759  0,006  Antidepressant
0,749  0,007  Mood disorders treatment
0,734  0,004  Alpha adrenoreceptor antagonist
0,718  0,004  Antiadrenergic
0,712  0,004  Muscle relaxant
0,710  0,004  Adrenaline antagonist
0,688  0,005  CYP2D6 inhibitor
0,669  0,022  Antineoplastic (lung cancer)
0,651  0,005  5 Hydroxytryptamine antagonist
0,655  0,009  Spasmolytic
0,646  0,004  Sigma receptor agonist
0,647  0,011  Antipsychotic
0,641  0,013  Antiparkinsonian
0,592  0,004  Skeletal muscle relaxant
0,590  0,004  Antiparkinsonian, rigidity relieving
0,579  0,009  Cardiodepressant
0,550  0,004  Alpha 2a adrenoreceptor antagonist
0,554  0,014  CYP2C19 inhibitor
0,542  0,004  Alpha 1 adrenoreceptor antagonist
0,544  0,008  Psychostimulant
0,549  0,024  Prostate cancer treatment
0,527  0,005  Dopamine antagonist
0,561  0,042  Caspase 9 stimulant
0,519  0,006  Antineoplastic (squamous cell carcinoma)
0,535  0,023  5 Hydroxytryptamine release inhibitor
0,529  0,020  Histamine release inhibitor
0,512  0,004  Alpha 1a adrenoreceptor antagonist
0,506  0,003  Dopamine D1 antagonist
0,503  0,010  Sedative
0,516  0,026  Respiratory analeptic
0,511  0,032  Antineoplastic (colon cancer)
0,512  0,034  Antineoplastic (colorectal cancer)
0,482  0,005  Dopamine D2 antagonist
0,480  0,007  5 Hydroxytryptamine 2 antagonist
0,476  0,006  Male reproductive disfunction treatment
0,474  0,005  5 Hydroxytryptamine 2A antagonist
0,494  0,026  CYP2D6 substrate
0,471  0,007  Attention deficit/hyperactivity disorder treatment
0,456  0,005  Erectile dysfunction treatment
0,473  0,027  Hepatic disorders treatment
0,471  0,025  Caspase 3 stimulant
0,472  0,030  Anxiolytic
0,445  0,004  Alpha 2b adrenoreceptor antagonist
0,443  0,004  Alpha 2c adrenoreceptor antagonist
0,482  0,058  Antineoplastic (breast cancer)
0,468  0,047  CYP3A4 substrate
0,426  0,005  Topoisomerase I inhibitor
0,427  0,006  Acetylcholine antagonist
0,424  0,007  Cholinergic antagonist
0,461  0,051  Transcription factor NF kappa B inhibitor
0,449  0,041  Vasodilator, peripheral
0,450  0,042  Cognition disorders treatment
0,406  0,005  Acetylcholine M1 receptor antagonist
0,429  0,031  Antineoplastic (glioma)
0,418  0,028  CYP3A4 inhibitor
0,415  0,025  Antineoplastic (glioblastoma multiforme)
0,422  0,040  Antineoplastic (ovarian cancer)
0,375  0,006  5 Hydroxytryptamine 1E antagonist
0,376  0,008  DNA intercalator
0,366  0,005  Dopamine D3 antagonist
0,445  0,093  Apoptosis agonist
0,356  0,004  LDLR expression enhancer
0,363  0,015  Antineoplastic (carcinoma)
0,355  0,009  Neurotrophic factor enhancer
0,355  0,010  Bipolar disorder treatment
0,407  0,062  Antileukemic
0,416  0,078  Analgesic
0,349  0,014  Pneumotoxic
0,341  0,007  Acetylcholine muscarinic antagonist
0,336  0,003  Alpha 2 adrenoreceptor agonist
0,340  0,007  5 Hydroxytryptamine 1A antagonist
0,346  0,014  Cholinergic
0,343  0,014  Topoisomerase II inhibitor
0,359  0,031  Acute neurologic disorders treatment
0,368  0,046  Analeptic
0,416  0,096  Antineoplastic (solid tumors)
0,365  0,047  CYP1A2 substrate
0,349  0,031  Dependence treatment
0,356  0,040  Antineoplastic (multiple myeloma)
0,319  0,004  Alpha adrenoreceptor agonist
0,362  0,050  Antineoplastic (melanoma)
0,349  0,041  DNA damaging
0,356  0,053  Vasodilator, coronary
0,341  0,038  Antineoplastic (renal cancer)
0,317  0,014  Antiparkinsonian, tremor relieving
0,339  0,037  Antineoplastic (liver cancer)
0,309  0,010  5 Hydroxytryptamine 1 antagonist
0,301  0,006  5 Hydroxytryptamine uptake inhibitor
0,295  0,003  Antineoplastic alkaloid
0,340  0,055  Antineoplastic (pancreatic cancer)
0,292  0,009  5 Hydroxytryptamine agonist
0,344  0,062  Antihypertensive
0,330  0,048  Antineoplastic (non-small cell lung cancer)
0,327  0,046  Cardiotonic
0,294  0,015  5 Hydroxytryptamine 2B antagonist
0,295  0,019  Antiischemic, cerebral
0,303  0,029  Hepatoprotectant
0,317  0,046  Antineoplastic (lymphoma)
0,273  0,009  5 Hydroxytryptamine 3E antagonist
0,275  0,011  Uterine stimulant
0,273  0,009  Antismoking
0,273  0,014  CDC-like kinase 1 inhibitor
0,263  0,004  Melanin-concentrating hormone receptor 1 antagonist
0,323  0,065  Antiischemic
0,261  0,004  Dopamine D5 antagonist
0,289  0,036  Anesthetic general
0,252  0,005  Phosphodiesterase V inhibitor
0,251  0,005  Alpha 1 adrenoreceptor agonist
0,289  0,048  DNA synthesis inhibitor
0,245  0,005  Acetylcholine M4 receptor antagonist
0,324  0,092  CYP2C9 substrate
0,236  0,004  Phosphodiesterase XI inhibitor
0,236  0,004  Phosphodiesterase 11A inhibitor
0,250  0,020  Acetylcholinesterase inhibitor
0,233  0,005  CDC-like kinase 3 inhibitor
0,272  0,044  Antineoplastic enhancer
0,231  0,004  Restless leg syndrome treatment
0,230  0,005  Acetylcholine M2 receptor antagonist
0,232  0,008  Dopamine agonist
0,262  0,038  Antialcoholic
0,317  0,094  Stroke treatment
0,228  0,008  Opioid kappa receptor antagonist
0,275  0,057  Vasodilator
0,221  0,005  Dopamine uptake inhibitor
0,234  0,018  Antitussive
0,217  0,005  Phosphodiesterase 5A inhibitor
0,214  0,002  Factor III inhibitor
0,259  0,051  Antiarrhythmic
0,224  0,022  Antiviral (Hepatitis B)
0,206  0,012  Acetylcholine nicotinic antagonist
0,272  0,082  Hypoxia-inducible factor 1 alpha inhibitor
0,222  0,033  Cystic fibrosis treatment
0,189  0,005  Acetylcholine M5 receptor antagonist
0,229  0,049  P-glycoprotein inhibitor
0,249  0,069  Tyrosine 3 hydroxylase inhibitor
0,238  0,062  Anticonvulsant
0,194  0,023  Butyrylcholinesterase inhibitor
0,227  0,056  Abortion inducer
0,257  0,088  CYP2C19 substrate
0,174  0,005  Nicotinic alpha4beta2 receptor antagonist
0,183  0,016  Alpha 1b adrenoreceptor antagonist
0,185  0,022  Antischistosomal
0,218  0,057  Antimigraine
0,164  0,006  Dopamine D2 agonist
0,261  0,103  12-Lipoxygenase inhibitor
0,185  0,027  Movement disorders treatment
0,284  0,128  Antiobesity
0,236  0,081  Tumour necrosis factor alpha release inhibitor
0,162  0,011  Neuronal nicotinic receptor antagonist
0,211  0,060  Sleep disorders treatment
0,152  0,004  Complement C5a chemotactic receptor antagonist
0,188  0,042  Carcinogenic, group 1
0,158  0,013  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,285  0,141  15-Lipoxygenase inhibitor
0,181  0,041  Raynaud's phenomenon treatment
0,155  0,017  Acetylcholine M3 receptor agonist
0,160  0,023  Opioid antagonist
0,178  0,041  Antifungal enhancer
0,157  0,021  Calcium antagonist
0,162  0,029  Nav1.1 sodium channel blocker
0,189  0,057  Liver fibrosis treatment
0,142  0,010  mTOR complex 2 inhibitor
0,232  0,100  Huntington's disease treatment
0,249  0,118  Antineoplastic (brain cancer)
0,214  0,084  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,141  0,012  Acetylcholine M3 receptor antagonist
0,159  0,032  Menstruation disorders treatment
0,231  0,104  Radiosensitizer
0,150  0,024  Breast cancer-resistant protein inhibitor
0,162  0,038  Cyclooxygenase 3 inhibitor
0,139  0,016  Tourette's syndrome treatment
0,141  0,019  Opioid mu receptor antagonist
0,254  0,135  Antineoplastic (small cell lung cancer)
0,129  0,012  Adrenaline uptake inhibitor
0,187  0,073  Nitric oxide antagonist
0,168  0,054  Pulmonary hypertension treatment
0,207  0,095  Antiprotozoal (Leishmania)
0,207  0,096  Antineoplastic (cervical cancer)
0,140  0,033  Sphingosine 1-phosphate receptor 2 agonist
0,128  0,021  mTOR complex 1 inhibitor
0,118  0,013  5 Hydroxytryptamine 1A agonist
0,174  0,069  Toxic, respiratory center
0,112  0,008  Opioid kappa receptor agonist
0,125  0,025  Acetylcholine nicotinic agonist
0,108  0,011  Nicotinic receptor alpha7 subunit antagonist
0,119  0,022  Dopamine D4 antagonist
0,100  0,005  Endothelin receptor antagonist
0,114  0,020  Alpha 1d adrenoreceptor antagonist
0,097  0,004  Vesicle monoamine transporter inhibitor
0,115  0,025  Analgesic, opioid
0,155  0,065  Lipid peroxidase inhibitor
0,094  0,005  Prolactin release inhibitor
0,130  0,042  Activin receptor-like kinase 4 inhibitor
0,108  0,019  5 Hydroxytryptamine 1 agonist
0,124  0,036  Prolactin inhibitor
0,126  0,039  DOPA decarboxylase inhibitor
0,189  0,102  Cyclic AMP phosphodiesterase inhibitor
0,113  0,026  5 Hydroxytryptamine 1F antagonist
0,096  0,010  5 Hydroxytryptamine 2 agonist
0,098  0,014  Opioid agonist
0,125  0,041  Antihistaminic
0,144  0,061  Tubulin antagonist
0,099  0,016  5 Hydroxytryptamine 3 agonist
0,177  0,093  Clk dual-specificity kinase inhibitor
0,174  0,093  CYP2B6 inhibitor
0,087  0,008  Potassium channel small-conductance Ca-activated blocker
0,148  0,071  Genotoxic
0,080  0,004  Endothelin B receptor antagonist
0,092  0,018  5 Hydroxytryptamine 5A antagonist
0,104  0,031  Antiprotozoal activity enhancer
0,108  0,036  Phosphodiesterase I inhibitor
0,098  0,026  Narcotic antagonist
0,181  0,110  Dyrk kinase inhibitor
0,082  0,012  Nicotinic alpha3beta2 receptor antagonist
0,158  0,088  ATPase inhibitor
0,074  0,005  Endothelin A receptor antagonist
0,086  0,019  Sigma receptor antagonist
0,133  0,066  Alpha-N-acetylglucosaminidase inhibitor
0,128  0,063  Antiviral (Papilloma)
0,124  0,059  Antiviral (Influenza B)
0,081  0,017  Potassium channel (Ca-activated) blocker
0,159  0,096  Phobic disorders treatment
0,104  0,042  Alpha 2d adrenoreceptor antagonist
0,097  0,035  Sodium/hydrogen exchanger 5 inhibitor
0,084  0,023  Glutamate (mGluR7) antagonist
0,074  0,013  5 Hydroxytryptamine 2C agonist
0,105  0,045  Histamine antagonist
0,068  0,009  5 Hydroxytryptamine 3B antagonist
0,065  0,006  Phosphodiesterase 6C inhibitor
0,079  0,021  5 Hydroxytryptamine 5 antagonist
0,085  0,028  Female sexual dysfunction treatment
0,261  0,205  Alzheimer's disease treatment
0,099  0,046  5 Hydroxytryptamine 2C antagonist
0,072  0,020  Dopamine transporter inhibitor
0,101  0,049  Phosphodiesterase 6D inhibitor
0,097  0,045  ATPase (Vacuolar H+) inhibitor
0,075  0,024  Nicotinic neuronal receptor agonist
0,131  0,080  Neurotrophic factor
0,094  0,043  Topoisomerase II alpha inhibitor
0,137  0,087  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,177  0,128  Cardiovascular analeptic
0,172  0,123  Antineoplastic (lymphocytic leukemia)
0,104  0,054  Nitric-oxide synthase inhibitor
0,193  0,144  Antiepileptic
0,078  0,029  5 Hydroxytryptamine 2A agonist
0,069  0,020  5 Hydroxytryptamine 7 agonist
0,136  0,088  Adenylate cyclase stimulant
0,120  0,073  Antiseptic
0,083  0,036  Phosphodiesterase VI inhibitor
0,129  0,083  Nav1.6 sodium channel blocker
0,068  0,025  Nicotinic alpha7 receptor agonist
0,051  0,007  Dopamine autoreceptor agonist
0,121  0,078  Papain-like protease (SARS coronavirus) inhibitor
0,124  0,081  Cocaine dependence treatment
0,057  0,014  Guanylate cyclase inhibitor
0,105  0,063  Expectorant
0,048  0,008  Phosphodiesterase 6B inhibitor
0,168  0,128  NOS2 expression inhibitor
0,078  0,038  Premenstrual syndrome treatment
0,077  0,037  Opioid delta receptor antagonist
0,043  0,005  Dopamine D1 agonist
0,133  0,096  Thrombolytic
0,044  0,006  Nociceptin (N/OFQ) receptor agonist
0,086  0,048  Glycine receptor antagonist
0,137  0,100  Prostatic (benign) hyperplasia treatment
0,064  0,027  Alpha tubulin antagonist
0,120  0,083  CNS active muscle relaxant
0,130  0,093  Antiviral (Influenza A)
0,059  0,024  Opioid mu receptor agonist
0,205  0,171  Antithrombotic
0,070  0,037  5 Hydroxytryptamine 7 antagonist
0,171  0,138  Myocardial infarction treatment
0,063  0,030  Ryanodine receptor antagonist
0,048  0,016  Nociceptin (N/OFQ) receptor antagonist
0,041  0,009  Nicotinic alpha3beta4 receptor agonist
0,185  0,153  Antineoplastic (sarcoma)
0,053  0,023  Nicotinic receptor alpha3 subunit antagonist
0,087  0,058  Acetylcholine agonist
0,155  0,125  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,059  0,030  Acetylcholine M2 receptor agonist
0,071  0,043  Acetylcholine M5 receptor agonist
0,076  0,048  Glutamate decarboxylase inhibitor
0,115  0,086  Renal failure treatment
0,056  0,029  Alpha 1L adrenoreceptor antagonist
0,083  0,057  Inducible nitric-oxide synthase inhibitor
0,051  0,025  Adenylate cyclase 1 inhibitor
0,082  0,056  Histamine H1 receptor antagonist
0,072  0,047  Dysmenorrhea treatment
0,031  0,007  Phosphodiesterase 6H inhibitor
0,031  0,007  Phosphodiesterase 6G inhibitor
0,046  0,021  Dopamine D5 agonist
0,152  0,129  HERG channel blocker
0,030  0,007  Vesicular acetylcholine transporter inhibitor
0,052  0,029  Nicotinic receptor alpha4 subunit antagonist
0,056  0,033  Alpha-mannosidase inhibitor
0,052  0,031  Topoisomerase II beta inhibitor
0,053  0,033  5 Hydroxytryptamine 4 antagonist
0,216  0,197  Antineoplastic (non-Hodgkin's lymphoma)
0,057  0,039  5 Hydroxytryptamine 6 antagonist
0,064  0,046  5 Hydroxytryptamine 1B antagonist
0,057  0,040  5 Hydroxytryptamine 3 antagonist
0,103  0,086  Microtubule formation inhibitor
0,102  0,086  Alkylator
0,074  0,059  Antitreponemal
0,070  0,055  Glycine receptor agonist
0,072  0,062  Estrogen receptor alpha antagonist
0,103  0,093  Glutamate receptor antagonist
0,167  0,158  Radioprotector
0,038  0,029  5 Hydroxytryptamine 2B agonist
0,158  0,149  VEGF expression inhibitor
0,090  0,083  Estrogen receptor beta antagonist
0,081  0,076  Tocolytic
0,019  0,015  Antibiotic Quinolone-like
0,039  0,034  Plasmepsin II inhibitor
0,125  0,122  CDC-like kinase 4 inhibitor
0,126  0,125  Prostate disorders treatment
0,104  0,103  Antiprotozoal (Amoeba)
0,042  0,041  AMPA receptor antagonist
0,117  0,116  UGT2B7 substrate
0,023  0,022  Sigma 2 receptor antagonist
0,014  0,014  NMDA receptor phencyclidine site antagonist

